See the DrugPatentWatch profile for yervoy

Yervoy Discount: How Long Will It Last?

Introduction

Yervoy, also known as ipilimumab, is a medication used to treat certain types of cancer, including melanoma and lung cancer. As a costly treatment, many patients and healthcare providers are concerned about the availability of discounts for this medication. In this article, we will explore the current status of Yervoy discounts and how long they are expected to last.

What is Yervoy?

Yervoy is a monoclonal antibody that works by boosting the body's immune system to fight cancer cells. It is approved by the FDA for the treatment of unresectable or metastatic melanoma and for the treatment of metastatic non-small cell lung cancer (NSCLC) with disease progression following platinum-based chemotherapy.

Yervoy Discount Programs

Several discount programs are currently available for Yervoy, including:

* Patient Assistance Programs (PAPs): Many pharmaceutical companies offer PAPs to help eligible patients access their medications at a reduced cost. For Yervoy, the manufacturer, Bristol-Myers Squibb, offers a PAP that provides free medication to eligible patients.
* Co-pay Cards: Co-pay cards are programs that help patients pay for their medication by reducing their out-of-pocket costs. For Yervoy, there are several co-pay cards available, including the Bristol-Myers Squibb Co-pay Card.
* Discount Cards: Discount cards are programs that offer discounts on prescription medications. For Yervoy, there are several discount cards available, including the GoodRx Discount Card.

How Long Will the Yervoy Discount Last?

The availability of Yervoy discounts is subject to change, and it is difficult to predict exactly how long they will last. However, we can look at the patent status of Yervoy to get an idea of when the discounts may expire.

According to DrugPatentWatch.com, the patent for Yervoy is set to expire in 2025. This means that once the patent expires, other pharmaceutical companies may be able to manufacture and sell generic versions of Yervoy, which could potentially reduce the cost of the medication.

Will the Yervoy Discount Last After the Patent Expires?

Even after the patent expires, it is possible that the Yervoy discount programs may continue to be available. Pharmaceutical companies may choose to continue offering discounts to patients who are unable to afford the medication, even if a generic version is available.

Additionally, the Affordable Care Act (ACA) requires pharmaceutical companies to provide discounts to patients who are eligible for Medicaid and other government-funded programs. This means that even if a generic version of Yervoy is available, patients who are eligible for Medicaid may still be able to access the medication at a reduced cost.

Conclusion

The availability of Yervoy discounts is subject to change, and it is difficult to predict exactly how long they will last. However, by understanding the patent status of Yervoy and the discount programs that are currently available, patients and healthcare providers can plan for the future and ensure that access to this medication is maintained.

FAQs

1. What is Yervoy used to treat?

Yervoy is used to treat certain types of cancer, including melanoma and lung cancer.

2. How long will the Yervoy discount last?

The availability of Yervoy discounts is subject to change, but the patent for Yervoy is set to expire in 2025.

3. Will the Yervoy discount last after the patent expires?

It is possible that the Yervoy discount programs may continue to be available even after the patent expires.

4. How can I access a Yervoy discount?

There are several ways to access a Yervoy discount, including patient assistance programs, co-pay cards, and discount cards.

5. Will a generic version of Yervoy be available after the patent expires?

Yes, a generic version of Yervoy may be available after the patent expires, which could potentially reduce the cost of the medication.

Cited Sources

1. DrugPatentWatch.com. (n.d.). Ipilimumab (Yervoy). Retrieved from <https://www.drugpatentwatch.com/patent/US-7449244>
2. Bristol-Myers Squibb. (n.d.). Yervoy (Ipilimumab) Patient Assistance Program. Retrieved from <https://www.bms.com/our-company/patient-assistance-program/yervoy-patient-assistance-program.html>
3. GoodRx. (n.d.). Yervoy Discount Card. Retrieved from <https://www.goodrx.com/yervoy/discount-card>